Safety and clinical efficacy of implanted neuroaugmentive spinal devices for the relief of pain.
When applied under the circumstances of minimal patient risk, as documented in this paper, implanted neuroaugmentive spinal devices are a reasonable means of therapy for selected severe pain problems. With presently developed screening techniques, a 50% good-to-excellent result was obtained in 198 patients predominently consisting of 'failed back surgery syndrome' (94%). These figures represent a very significant improvement in success of treatment for this group of patients when compared to other present modes of therapy. With continued optimization of the use of spinal neuroaugmentive devices, it is likely that future clinical success can be significantly improved.